Study on the clinical outcomes of COVID-19 infection and immune responses following the third booster dose of inactivated COVID-19 vaccine in hematologic disease patients
Three inactivated vaccine doses were associated with higher NAb and IgG positivity overall and among three-dose recipients, NAb positivity was lower with hematologic diseases than without documented hematologic disease or solid tumors, and intervals were modestly longer with hematologic diseases.